Advertisement

The Importance of Diversity in Clinical Trials for Hepatitis C

Diversity is important in clinical trials due to genetic, metabolic, social, economic, and cultural factors that contribute to disease outcomes.

Featured Content

article

Steps to Diagnosing and Getting Treatment for Hep C

What to expect during and after hep C screening and how to decide on a treatment plan.
article

Why Hepatitis C is Called a "Quiet Killer"

Most people with hepatitis C have no symptoms until the disease has caused serious liver damage. Here’s what you need to know about hep C diagnosis.
article

How to Emotionally Support Someone with Hep C

Learn simple and appreciated ways to help someone cope with hepatitis C.
article

Hep C Treatment for Patients on Medicaid

A look at some of the challenges people insured through Medicaid may face when seeking treatment for hep C.